Pfizer has made a $35 million investment — through its Pfizer “Breakthrough Growth Initiative” — in autoimmune disease treatment biotechnology company Anokion.
Read the full post on Becker's Hospital Review - Healthcare News
Pfizer invests $35M in biotech company
